Matinas BioPharma Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Going Concern and Plan of Operations (Details Textual) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Going Concern And Plan Of Operation [Line Items]
Deficit accumulated during development stage	$ (19,026,407)		$ (19,026,407)		$ (14,051,764)
Net loss	$ (2,404,532)	$ (2,425,872)	$ (4,974,643)	$ (4,564,895)	$ 10,200,000

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.